CClinicalTrials.gg
WithdrawnNCT01075165Updated Feb 4, 2015

Efficacy of Spray Silicone in Alteration of Burn Scar

An interventional study of silicone spray and saline spray in Burn Scar, sponsored by United States Army Institute of Surgical Research. Withdrawn at 2 sites in United States. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2015-02-04.

Sponsored by United States Army Institute of Surgical Research · Not applicable, Interventional, and Treatment

Why this study was withdrawn
IRB closed study due to no enrollment over 4 yrs
Phase
Not applicable
Study type
Interventional
Enrollment
0
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

In a burn population, conduct a prospective, double-blinded, randomized, controlled clinical trial to determine the ability of spray silicone to alter the physical characteristics of burn scar compared to a placebo.

Read the detailed description

At study enrollment, the patient's scar will be evaluated using the vascularity category of the Vancouver Scar Scale. The vascularity rating is a four item likert scale that rates the scar as normal (0), pink (1), red (2), or purple (3). Scar height will be measured using a diagnostic ultrasound unit with a 20MHz transducer.27 Digital photographs will be taken with a color spectrum scale placed next to the scar. Laser Doppler imaging (LDI) will be used to assess scar perfusion at the regions of interest to determine whether treatment with silicone spay results in measureable changes in scar perfusion as well as to establish the time course over which these changes may be expected to occur. A spray template will then be created for the patient using thermoplastic material. It will consist of three (3) circles with an area of .785 inches, spaced one inch apart, which will section off the test areas. One of the areas will be treated with the spray silicone, one area will be sprayed with spray saline (to serve as a placebo), the remaining area will not be treated and therefore will serve as the control. The order in which each area is treated will be determined using a randomized block, computerized allocation developed by the study statistician. The spray silicone and spray saline will be applied via containers that conceal the contents and the patients will not be allowed to observe the application of the silicone or saline. Although the patient will be blinded to the test areas that have substances applied to them, there will be no blinding in regard to the control area that receives no treatment. The substances will be applied by trained investigators each weekday for a 12-week period to ensure the method of application is consistent. Both substances will be applied at a distance of 1.5 inches from the surface of the skin for a one second period. Patients will be instructed not to wash the treated area for 24 hours and not to apply pressure garments over the area. The treated areas will be re-evaluated and photographed every two weeks for a 12 week period. The clinician conducting the initial scar evaluation and re-evaluations will be blinded to the scar treatment. Each patient will also complete a scar assessment scale.28 The patient's participation in the study will be concluded 12 weeks after the initial treatment and he/she will be given the option of continued use of the spray silicone, resumption/commencement of pressure garment use or the provision of another appropriate scar management program. Because burn scar can take several months to years to reach the scar maturation phase, the patient will still be a candidate for an alternate scar management program if at the conclusion of this study they see no benefit from the use of spray silicone. If at any time during the 12-week period the clinician determines that the scar is worsening, then the patient will be removed from the study and offered another scar management program.

02

Conditions studied

  • Burn Scar

Browse trials for

Keywords

  • silicone
  • burn scar
  • hypertrophic scar
  • keloid
  • scar assessment
  • abnormal scarring
  • Burn patients
03

In context

Cicatrix

307 studies on the registry are indexed under Cicatrix; 50 are open to participants now.

Browse Cicatrix studies →

Lead sponsor

United States Army Institute of Surgical Research is the lead sponsor of 24 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Military or civilian
  2. Between 18-60 years of age
  3. Subjects have experienced a deep partial thickness burn injury with a minimal size 2x6 inches in dimension
  4. Burn wounds must have healed by secondary intention
  5. Available for initial scar evaluation and bi-weekly assessments (30 minutes) and application of silicone and saline every weekday (5 minutes)

Exclusion criteria

Exclusion Criteria:

  1. \<18 or >60 years
  2. Available burn scar size is less then 2x6 inches
  3. Burn wounds healed by sheet grafting
  4. Unavailable for initial scar evaluation and bi-weekly assessments (30 minutes) and application of silicone and saline every weekday (5 minutes)
  5. Pre-existing medical conditions that have the potential to impair healing (i.e. Diabetes, Peripheral Arterial Disease, etc).
  6. Pregnant women will be excluded from the study because of the potential for pregnancy hormones to exacerbate the burn scar
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Single group
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
0 participants (actual)

Study arms

  • Experimental
    Silicone Spray

    Apply spray silicone

    Other: silicone spray

  • Placebo comparator
    Saline Spray

    Apply Saline Spray

    Other: saline spray

Interventions

  • Othersilicone spray

    application of silicone spray to predefined area qd 12 weeks

  • Othersaline spray

    application of saline spray to predefined area qd 12 weeks

06

What researchers measure

Primary outcomes

  1. Vascularity rating, scar height, and color of burn scar (spray silicone vs placebo vs untreated)

    Time frame: every 2 weeks for a 12 week period

07

Study locations

2 sites
  • US Army Institute of Surgical Research
    Fort Sam Houston, Texas 78234, United States
  • USAISR
    Fort Sam Houston, Texas 78234, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 4, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01075165
Lead sponsor
United States Army Institute of Surgical Research
Responsible party
Sponsor
First posted
Feb 24, 2010
Start date
Mar 2011
Primary completion
Dec 2014
Completion
Dec 2014
Last update
Feb 4, 2015

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Feb 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion